Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Buy
51
XBI Quote, Financials, Valuation and Earnings
Last price:
$91.91
Seasonality move
:
3.53%
Day range:
$89.34 - $91.97
52-week range:
$81.14 - $105.47
Dividend yield:
0.16%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
10M
Avg. volume:
10.1M
1-year change:
10.43%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingSPDR S&P Biotech ETF has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, SPDR S&P Biotech ETF has an estimated downside of -- from its current price of $91.28.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $91.28.
Fair Value
-
According to the consensus of 0 analysts, SPDR S&P Biotech ETF has -- downside to fair value with a price target of -- per share.
XBI vs. S&P 500
-
Over the past 5 trading days, SPDR S&P Biotech ETF has underperformed the S&P 500 by -0.29% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SPDR S&P Biotech ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SPDR S&P Biotech ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter SPDR S&P Biotech ETF reported revenues of --.
Earnings Growth
-
SPDR S&P Biotech ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SPDR S&P Biotech ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-24 | 2023-12-24 | 2023-12-24 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-24 | 2021-12-24 | 2022-12-24 | 2023-12-24 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-24 | 2023-12-24 | 2023-12-24 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
XBI
Sector
Market Cap
--
--
Price % of 52-Week High
86.55%
--
Dividend Yield
0.16%
--
Shareholder Yield
--
--
1-Year Price Total Return
10.43%
--
Beta (5-Year)
0.956
--
Dividend yield:
0.16%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$93.12
200-day SMA
Sell
Level
$95.07
Bollinger Bands (100)
Sell
Level
95.14 - 100.84
Chaikin Money Flow
Buy
Level
454M
20-day SMA
Sell
Level
$96.26
Relative Strength Index (RSI14)
Sell
Level
37.18
ADX Line
Buy
Level
11.1
Williams %R
Neutral
Level
-76.4967
50-day SMA
Sell
Level
$97.53
MACD (12, 26)
Sell
Level
-1.75
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
348.6M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, XBI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XBI average analyst price target in the past 3 months is --.
-
Where Will SPDR S&P Biotech ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that SPDR S&P Biotech ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About SPDR S&P Biotech ETF?
Analysts are divided on their view about SPDR S&P Biotech ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SPDR S&P Biotech ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is SPDR S&P Biotech ETF's Price Target?
The price target for SPDR S&P Biotech ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is XBI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SPDR S&P Biotech ETF is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of XBI?
You can purchase shares of SPDR S&P Biotech ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SPDR S&P Biotech ETF shares.
-
What Is The SPDR S&P Biotech ETF Share Price Today?
SPDR S&P Biotech ETF was last trading at $91.91 per share. This represents the most recent stock quote for SPDR S&P Biotech ETF. Yesterday, SPDR S&P Biotech ETF closed at $91.28 per share.
-
How To Buy SPDR S&P Biotech ETF Stock Online?
In order to purchase SPDR S&P Biotech ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.9% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.4% over the past day.
